Mendelspod
Subscribe
Sign in
Home
Archive
About
Latest
Top
Discussions
Digital Controls for Cancer Drug Trials? Irina Babina, Concr
On today’s show, a fascinating discussion about digital twins for medical research— leading to the 64 million dollar question of how much of the current…
May 15
•
Theral Timpson
2
1
29:49
Solexa Co-Inventor Shankar Balasubramanian on Six-Base Sequencing and What's Next in Genomics
An inventor of Solexa sequencing by synthesis has a new idea.
May 7
•
Theral Timpson
2
2
37:59
April 2026
The Next Frontier in Biology: Physics? Erdinc Sezgin of the Karolinska Institute
There’s a famous line attributed to Ernest Rutherford, the father of nuclear physics: “All science is either physics or stamp collecting.” It’s still…
Apr 30
•
Theral Timpson
3
1
32:54
The Case for a 6-Base Genome with Peter Fromen, CEO of Biomodal
You’ve heard of 5-base genomics.
Apr 28
•
Theral Timpson
3
1
35:29
The Eligible But Under-Tested: Genomic Medicine in 2026 with Damon Hostin, Illumina
What is the value of someone’s genome over their life?
Apr 14
•
Theral Timpson
8
1
39:36
Spatial Transcriptomics Is Changing How We Do Biology: Fei Chen, The Broad Institute
Fei Chen of the Broad Institute describes the original problem simply: genomics gave us powerful inventories of gene expression, while microscopy gave…
Apr 9
•
Theral Timpson
9
1
1
31:42
Beyond GLP-1: Why Peptides Are Back at the Center of Drug Discovery with Charlie Johannes and Tomi Sawyer
Peptides are having a moment.
Apr 7
•
Theral Timpson
8
1
44:06
From the Archives: Inventor Mark Kokoris Debuts Roche’s New SBX Sequencer
It was the biggest story in sequencing last year: Mark Kokoris, head of SBX sequencing at Roche and inventor of the technology, joins Mendelspod to talk…
Apr 2
•
Theral Timpson
7
1
35:51
March 2026
Why Do Some Animals Live Ten Times Longer? Pursuing the Science of Aging with Steve Austad
Why do some animals live ten times longer than others?
Mar 17
•
Theral Timpson
2
1
38:22
MRD Testing: From Residual Disease to Real Decisions with Chris Hourigan and Gary Pestano
Molecular residual disease, or MRD, has been part of oncology’s vocabulary for decades.
Mar 10
•
Theral Timpson
2
1
2
33:32
Early vs Late Recurrence: How Multimodal AI Is Changing Breast Cancer Prognosis with George Sledge, Caris Life Sciences
For two decades, tests like Oncotype DX have helped oncologists decide which early-stage breast cancer patients should receive chemotherapy.
Mar 5
•
Theral Timpson
2
1
35:02
The Dark Genome with Author Sudhakaran Prabakaran
We began this podcast back around the time the ENCODE project announced that much of the genome was biochemically active.
Mar 3
•
Theral Timpson
5
2
37:16
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
